Caspase Inhibitor Diminishes Caffeic Acid-induced Apoptosis in Osteosarcoma Cells

Ferry Sandra, Karina Febriani Hudono, Amelia Astriani Putri, Chantika Amardhia Paramita Putri


BACKGROUND: Caffeic acid has been shown to induce apoptosis in MG63 osteosarcoma cells. Along with the apoptotic induction, caffeic acid was shown to activate caspase-8, -9 and -3. However, the role of caspase in mediating caffeic acid-induced apoptosis in MG63 cells are not clear yet. In this study, caspase role was further investigated by inhibiting caspase activity in the caffeic acid-induced apoptosis system in the MG63 cells.

METHODS: MG63 cells were cultured, starved, pretreated with/without Z-VAD FMK and treated with/without 10 µg/mL caffeic acid. To quantify the number of apoptotic MG63 cells, Sub-G1 method was performed. The caffeic acid-induced apoptotic morphology was confirmed with 4',6-diamidino-2-phenylindole (DAPI) staining and Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay. Meanwhile, to detect apoptotic underlying mechanism, immunoblotting was performed to detect caspase-8, -9 and -3.

RESULTS: MG63 cells were significantly induced into apoptosis with the treatment of 10 µg/mL caffeic acid for 48 hours. However, pretreatment of 100 µM Z-VAD-FMK, a pan caspase inhibitor, for 2 hours, the percentage of apoptotic MG63 cells was significantly diminished. The apoptotic phenomenon induced by caffeic acid as well as the inhibition of Z-VAD-FMK were confirmed by DAPI staining and TUNEL assay. Cleaved caspase-8, -9 and -3 were formed markedly upon the treatment of caffeic acid. Pretreatment of 100 µM Z-VAD-FMK could inhibit the cleaved caspase-8, -9 and -3.

CONCLUSION: Taken together, caffeic acid has the potential to induce apoptosis in MG63 cells, specifically through the caspase signaling pathway.

KEYWORDS: caffeic acid, apoptosis, MG63, caspase, Z-VAD FMK

Full Text:



Ta HT, Dass CR, Choong PF, Dunstan DE. Osteosarcoma treatment: state of the art. Cancer Metastasis Rev. 2009; 28: 247-63, CrossRef.

Grohar PJ, Helman LJ. Prospects and challenges for the development of new therapies for Ewing sarcoma. Pharmacol Ther. 2013; 137: 216-24, CrossRef.

Tanaka M, Ishiguro K, Oki T, Okuno S. Functional components in sweetpotato and their genetic improvement. Breed Sci. 2017; 67: 52-61, CrossRef.

Tang QY, Kukita T, Ushijima Y, Kukita A, Nagata K, Sandra F, et al. Regulation of osteoclastogenesis by Simon extracts composed of caffeic acid and related compounds: successful suppression of bone destruction accompanied with adjuvant-induced arthritis in rats. Histochem Cell Biol. 2006; 125: 215-25, CrossRef.

Sandra F, Kukita T, Tang QY, Iijima T. Caffeic acid inhibits NFkappaB activation of osteoclastogenesis signaling pathway. Indones Biomed J. 2011; 3(3): 216-22, CrossRef.

Sandra F, Kukita T, Muta T, Iijima T. Caffeic acid inhibited receptor activator of nuclear factor κB ligand (RANKL)-tumor necrosis factor (TNF) α-TNF receptor associated factor (TRAF) 6 induced osteoclastogenesis pathway. Indones Biomed J. 2013; 5(3): 173-8, CrossRef.

Kannaiyan R, Hay HS, Rajendran P, Li F, Shanmugam MK, Vali S, et al. Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-κB and STAT3 regulated gene products in multiple myeloma cells. Br J Pharmacol. 2011; 164: 1506-21, CrossRef.

Dziedzic A, Kubina R, Kabała-Dzik A, Tanasiewicz M. Induction of cell cycle arrest and apoptotic response of head and neck squamous carcinoma cells (Detroit 562) by caffeic acid and caffeic acid phenethyl ester derivative. Evid Based Complement Alternat Med. 2017; 2017: 6793456, CrossRef.

Spagnol CM, Di Filippo LD, Isaac VLB, Corrêa MA, Salgado HRN. Caffeic acid in dermatological formulations: in vitro release profile and skin absorption. Comb Chem High Throughput Screen. 2017. doi: 10.2174/1386207320666170602090448, CrossRef.

Bertelli AA. Wine, research and cardiovascular disease: instructions for use. Atherosclerosis. 2007; 195: 242-7, CrossRef.

Sandra F, Sidharta MA. Caffeic acid induced apoptosis in MG63 osteosarcoma cells through activation of caspases. Mol Cell Biomed Sci. 2017; 1: 28-33, CrossRef.

Sandra F, Khosravi-Far R. Survivin S81A enhanced TRAIL's activity in inducing apoptosis. Indones Biomed J. 2010; 2: 113-7, CrossRef.

Sandra F, Sudiono J, Sidharta EA, Sunata EP, Sungkono DJ, Dirgantara Y, et al. Conditioned media of human umbilical cord blood mesenchymal stem cell-derived secretome induced apoptosis and inhibited growth of HeLa cells. Indones Biomed J. 2014; 6(1): 57-62, CrossRef.

Sandra F, Hendarmin L, Nakao Y, Nakamura N, Nakamura S. Inhibition of Akt and MAPK pathways elevated potential of TNFalpha in inducing apoptosis in ameloblastoma. Oral Oncol. 2006; 42: 39-45, CrossRef.

Sandra F, Oktaviono YH, Widodo MA, Dirgantara Y, Chouw A, Sargowo D. Endothelial progenitor cells proliferated via MEK-dependent p42 MAPK signaling pathway. Mol Cell Biochem. 2015; 400: 201-6, CrossRef.

Sandra F, Hendarmin L, Nakao Y, Nakamura N, Nakamura S. TRAIL cleaves caspase-8, -9 and -3 of AM-1 cells: a possible pathway for TRAIL to induce apoptosis in ameloblastoma. Tumor Biol. 2005; 26: 258-64, CrossRef.

Rizal MI, Sandra F. Brucea javanica leaf extract activates caspase-9 and caspase-3 of mitochondrial apoptotic pathway in human oral squamous cell carcinoma. Indones Biomed J. 2016; 8: 43-8, CrossRef.

Wicaksono BD Tangkearung E, Sandra F. Brucea javanica leaf extract induced apoptosis in human oral squamous cell carcinoma (HSC2) cells by attenuation of mitochondrial membrane permeability. Indones Biomed J. 2015; 7: 107-10, CrossRef.

Arung ET, Wicaksono BD, Handoko YA, Kusuma IW, Shimizu K, Yulia D, et al. Cytotoxic effect of artocarpin on T47D cells. J Nat Med. 2010; 64: 423-9, CrossRef.

Arung ET, Wicaksono BD, Handoko YA, Kusuma IW, Yulia D, Sandra F. Anti-cancer properties of diethylether extract of wood from Sukun (Artocarpus altilis) in human breast cancer (T47D) cells. Trop J Pharm Res. 2009; 8: 317-24, CrossRef.


Indexed by:






The Prodia Education and Research Institute